-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AU-007 in Transitional Cell Cancer (Urothelial Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AU-007 in Transitional Cell Cancer (Urothelial Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AU-007 in Transitional Cell Cancer (Urothelial Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tesamorelin Acetate in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tesamorelin Acetate in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Tesamorelin acetate (TH-9507, Hex-hGRF, Egrifta, Egrifta...
-
Product Insights
Itasca County Pumped Storage
Itasca County Pumped Storage is a Hydro project located in Minnesota, United States. The project is owned and being developed by SV Hydro LLC. The project is expected to come online in 2033. Empower your strategies with our Itasca County Pumped Storage report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT in Triple-Negative Breast Cancer (TNBC) Drug Details: Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT in Metastatic Breast Cancer Drug Details: Bria-IMT (BriaVax) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tesamorelin Acetate in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tesamorelin Acetate in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tesamorelin Acetate in Non-Alcoholic Steatohepatitis (NASH) Drug Details: Tesamorelin acetate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifamycin Sodium CR in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifamycin Sodium CR in Hepatic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifamycin Sodium CR in Hepatic Encephalopathy Drug Details: Rifamycin...